310
Views
11
CrossRef citations to date
0
Altmetric
Original Articles: Research

The G protein-coupled receptor CysLT1 mediates chemokine-like effects and prolongs survival in chronic lymphocytic leukemia

, , , , , , , & show all
Pages 665-673 | Received 09 Aug 2011, Accepted 16 Sep 2011, Published online: 27 Apr 2012

References

  • Sarau HM, Ames RS, Chambers J, . Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor. Mol Pharmacol 1999;56:657–663.
  • Claesson HE, Dahlen SE. Asthma and leukotrienes: antileukotrienes as novel anti-asthmatic drugs. J Leukemia & Lymphoma. 1999;245: 205–227.
  • Feinmark SJ, Cannon PJ. Endothelial cell leukotriene C4 synthesis results from intercellular transfer of leukotriene A4 synthesized by polymorphonuclear leukocytes. J Biol Chem 1986;261:16466–16472.
  • Denzlinger C. Biology and pathophysiology of leukotrienes. Crit Rev Oncol Hematol 1996;23:167–223.
  • Busse WW. Leukotrienes and inflammation. Am J Respir Crit Care Med 1998;157:S210–S213.
  • Christie PE, Henderson WR, Jr. Lipid inflammatory mediators: leukotrienes, prostaglandins, platelet-activating factor. Clin Allergy Immunol 2002;16:233–254.
  • Lynch KR, O'Neill GP, Liu Q, . Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature 1999;399:789–793.
  • Heise CE, O'Dowd BF, Figueroa DJ, . Characterization of the human cysteinyl leukotriene 2 receptor. J Biol Chem 2000;275:30531–30536.
  • Singh RK, Gupta S, Dastidar S, . Cysteinyl leukotrienes and their receptors: molecular and functional characteristics. Pharmacology 2010;85:336–349.
  • Evans JF. Cysteinyl leukotriene receptors. Prostaglandins Other Lipid Mediat. 2002;68–69:587–597.
  • Bautz F, Denzlinger C, Kanz L, . Chemotaxis and transendothelial migration of CD34(+) hematopoietic progenitor cells induced by the inflammatory mediator leukotriene D4 are mediated by the 7-transmembrane receptor CysLT1. Blood 2001;97:3433–3440.
  • Sjostrom M, Johansson AS, Schroder O, . Dominant expression of the CysLT(2) receptor accounts for calcium signaling by cysteinyl leukotrienes in human umbilical vein endothelial cells. J Leukemia & Lymphoma. 2003;23:E37–E41.
  • Boehmler AM, Drost A, Jaggy L, . The CysLT1 ligand leukotriene D4 supports alpha4beta1- and alpha5beta1-mediated adhesion and proliferation of CD34+hematopoietic progenitor cells. J Immunol 2009;182:6789–6798.
  • Lindgren JA, Stenke L, Mansour M, . Formation and effects of leukotrienes and lipoxins in human bone marrow. J Lipid Mediat 1993;6:313–320.
  • Boehmler AM, Denzlinger C, Kanz L, . Potential role of cysteinyl leukotrienes in trafficking and survival of hematopoietic progenitor cells. Adv Exp Med Biol 2003;525:25–28.
  • Möhle R, Bautz F, Rafii S, . The chemokine receptor CXCR-4 is expressed on CD34+hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. Blood 1998;91:4523–4530.
  • Xue X, Cai Z, Seitz G, . Differential effects of G protein coupled receptors on hematopoietic progenitor cell growth depend on their signaling capacities. Ann N Y Acad Sci 2007;1106:180–189.
  • Aiuti A, Turchetto L, Cota M, . Human CD34(+) cells express CXCR4 and its ligand stromal cell-derived factor-1. Implications for infection by T-cell tropic human immunodeficiency virus. Blood 1999;94:62–73.
  • Lapidot T, Dar A, Kollet O. How do stem cells find their way home? Blood 2005;106:1901–1910.
  • Peled A, Petit I, Kollet O, . Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 1999;283:845–848.
  • Ma Q, Jones D, Springer TA. The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment. Immunity 1999;10:463–471.
  • Lataillade JJ, Clay D, Dupuy C, . Chemokine SDF-1 enhances circulating CD34(+) cell proliferation in synergy with cytokines: possible role in progenitor survival. Blood 2000;95:756–768.
  • Kanaoka Y, Boyce JA. Cysteinyl leukotrienes and their receptors: cellular distribution and function in immune and inflammatory responses. J Immunol 2004;173:1503–1510.
  • Rochette C, Nicholson DW, Metters KM. Identification and target-size analysis of the leukotriene D4 receptor in the human THP-1 cell line. Biochim Biophys Acta 1993;1177:283–290.
  • Chiorazzi N, Rai KR, Ferrarini M. Chronic Lymphocytic Leukemia. N Engl J Med 2005;352:804–815.
  • Möhle R, Failenschmid C, Bautz F, . Overexpression of the chemokine receptor CXCR4 in B cell chronic lymphocytic leukemia is associated with increased functional response to stromal cell-derived factor-1 (SDF-1). Leukemia 1999;13:1954–1959.
  • Burger JA, Burger M, Kipps TJ. Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells. Blood 1999;94:3658–3667.
  • Burger M, Hartmann T, Krome M, . Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells. Blood 2005;106:1824–1830.
  • Sipkins DA, Wei X, Wu JW, . In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment. Nature 2005;435:969–973.
  • Vandenberghe PA, Ceuppens JL. Flow cytometric measurement of cytoplasmic free calcium in human peripheral blood T lymphocytes with fluo-3, a new fluorescent calcium indicator. J Immunol Methods 1990;127:197–205.
  • Bandeira-Melo C, Woods LJ, Phoofolo M, . Intracrine cysteinyl leukotriene receptor-mediated signaling of eosinophil vesicular transport-mediated interleukin-4 secretion. J Exp Med 2002;196:841–850.
  • Lehman JA, Paul CC, Baumann MA, . MAP kinase upregulation after hematopoietic differentiation: role of chemotaxis. Am J Physiol Cell Physiol 2001;280:C183–C191.
  • Hii CS, Anson DS, Costabile M, . Characterization of the MEK5-ERK5 module in human neutrophils and its relationship to ERK1/ERK2 in the chemotactic response. J Biol Chem 2004;279:49825–49834.
  • Lamoureux J, Stankova J, Rola-Pleszczynski M. Leukotriene D4 enhances immunoglobulin production in CD40-activated human B lymphocytes. J Allergy Clin Immunol 2006;117:924–930.
  • Möhle R, Bautz F, Rafii S, . Regulation of transendothelial migration of hematopoietic progenitor cells. Ann N Y Acad Sci 1999;872:176–185.
  • Nielsen CK, Campbell JI, Ohd JF, . A novel localization of the G-protein-coupled CysLT1 receptor in the nucleus of colorectal adenocarcinoma cells. Cancer Res 2005;65:732–742.
  • Massoumi R, Nielsen CK, Azemovic D, . Leukotriene D4-induced adhesion of Caco-2 cells is mediated by prostaglandin E2 and upregulation of alpha2beta1-integrin. Exp Cell Res 2003;289:342–351.
  • Ohd JF, Nielsen CK, Campbell J, . Expression of the leukotriene D4 receptor CysLT1, COX-2, and other cell survival factors in colorectal adenocarcinomas. J Leukemia & Lymphoma. 2003;124:57–70.
  • Massoumi R, Sjolander A. The role of leukotriene receptor signaling in inflammation and cancer. ScientificWorldJournal 2007;7:1413–1421.
  • Kuppers R, Klein U, Schwering I, . Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling. J Leukemia & Lymphoma. 2003;111:529–537.
  • Alizadeh AA, Eisen MB, Davis RE, . Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503–511.
  • Stratowa C, Loffler G, Lichter P, . cDNA microarray gene expression analysis of B-cell chronic lymphocytic leukemia proposes potential new prognostic markers involved in lymphocyte trafficking. J Leukemia & Lymphoma. 2001;91:474–480.
  • Runarsson G, Liu AQ, Mahshid Y, . Leukotriene B-4 plays a pivotal role in CD40-dependent activation of chronic B lymphocytic leukemia cells. Blood 2005;105:1274–1279.
  • Stenke L, Sjolinder M, Miale TD, . Novel enzymatic abnormalities in AML and CML in blast crisis: elevated leucocyte leukotriene C-4 synthase activity paralleled by deficient leukotriene biosynthesis from endogenous substrate. J Leukemia & Lymphoma. 1998;101:728–736.
  • Paul S, Belinsky MG, Shen H, . Structure and in vitro substrate specificity of the murine multidrug resistance-associated protein. Biochemistry 1996;35:13647–13655.
  • Fleisch JH, Rinkema LE, Haisch KD, . LY171883, 1-less than 2-hydroxy-3-propyl-4-less than 4-(1H-tetrazol-5-yl) butoxy greater than phenyl greater than ethanone, an orally active leukotriene D4 antagonist. J Pharmacol Exp Ther 1985;233:148–157.
  • Matsuyama M, Funao K, Hayama T, . Relationship between cysteinyl-leukotriene-1 receptor and human transitional cell carcinoma in bladder. Urology 2009;73:916–921.
  • Matsuyama M, Hayama T, Funao K, . Overexpression of cysteinyl LT1 receptor in prostate cancer and CysLT1R antagonist inhibits prostate cancer cell growth through apoptosis. Oncol Rep 2007;18:99–104.
  • Abadoglu O, Mungan D, Aksu O, . The effect of montelukast on eosinophil apoptosis: induced sputum findings of patients with mild persistent asthma. Allergol Immunopathol (Madr ) 2005;33:105–111.
  • Burger JA, Burkle A. The CXCR4 chemokine receptor in acute and chronic leukaemia: a marrow homing receptor and potential therapeutic target. Br J Haematol 2007;137:288–296.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.